CRISPR

Curing disease with CRISPR with Trevor Martin from Mammoth Biosciences

Welcome back to Found, where we get the stories behind the startups. This week Darrell and Becca are joined by Trevor Martin the co-founder and CEO of Mammoth Biosciences, a startup that uses CRISPR t

Andreessen Horowitz backs SCiFi Foods as it develops cell-cultivated, plant-based burger

The company is using both plant-based and real cultivated beef cells in its approach to grow meat from animal cells at large-scale and more affordably.

Colossal grabs $60 million Series A for moonshot mammoth project

Colossal, the company known for its mission to resurrect a woolly mammoth (or at least, an elephant with some very mammoth-like traits), is back with $60 million in Series A funding. But despite the f

Phytoform plants $5.7M into climate-resistant crop technology

The success of CRISPR technology in agriculture has been well documented as a way to manipulate plant genomes to make them more pest and climate resistant and grow more consistent products.

How Colossal sold investors on a quest to resurrect a woolly mammoth

There are a growing number of companies interested in CRISPR’s potential to upend medicine. It’s probably safe to say there’s only one company interested in using the gene-editing system to

Breakout ‘CRISPR platform’ company Mammoth Biosciences is officially a unicorn

The CRISPR-based biotech startup Mammoth Biosciences is officially a unicorn, the company says.  The billion-dollar valuation comes on the back of a $150 million Series D round led by Redmile Group,

New clinical trial data from Locus Biosciences shows promise in CRISPR-Cas3 technology

Antibiotic resistance is one of the biggest potential threats to global health today. But Locus Biosciences is hoping that their crPhage technology might provide a new solution. Based in North Carolin

Tech’s role in the COVID-19 response: Assist, don’t reinvent

The pandemic has affected just about every business in the world, but tech has also geared up to fight back in its own way, as we found out from speakers at Disrupt 2020. But technology has opted to t

Nobel laureate Jennifer Doudna shares her perspective on COVID-19 and CRISPR

CRISPR co-discoverer Jennifer Doudna was named a Nobel laureate in Chemistry today, sharing the honour with Emmanuelle Charpentier. We had the opportunity to speak to Doudna recently at our TechCrunch

Scribe Therapeutics launches a platform for engineering CRISPR-based therapeutics

A new company called Scribe Therapeutics founded by two former members of CRISPR pioneer Jennifer Doudna’s UC Berkeley genetics lab (alongside Doudna herself) launched on Tuesday, debuting a pla

Daily Crunch: Twitter tightens security ahead of election

Twitter takes preemptive steps to avoid election-related hacks, we check out the new Apple Watches and Facebook launches new business tools. This is your Daily Crunch for September 17, 2020. The big s

Jennifer Doudna sees CRISPR gene-editing tech as a Swiss Army knife for COVID-19 and beyond

Jennifer Doudna, one of the pioneers of the gene-editing technique known as CRISPR, thinks the biotech tool could be an essential one for combating COVID-19 and future pandemics. Due to its capacity t

Students get 60% off passes to Disrupt 2020

Budget-strapped students, this post is for you. We have a limited number of discount passes to Disrupt 2020 for $125 a pop. Buy your student pass now, before one of two things happen. One, we run out

Mission Bio raises $70 million to help scale its tech for improving the development of targeted cancer therapies

California-based startup Mission Bio has raised a new $70 million Series C funding round, led by Novo Growth and including participation from Soleus Capital and existing investors Mayfield, Cota and A

Mammoth Biosciences lands exclusive license to new CRISPR proteins that could boost gene editing precision

CRISPR pioneer Mammoth Biosciences has secured an exclusive license to a new family of CRISPR proteins. Obtained from UC Berkeley, the license covers R&D and commercialization across all potential

Mammoth Biosciences’s CRISPR-based COVID-19 test receives NIH funding through RADx program

CRISPR tech startup Mammoth Biosciences is among the companies that revealed backing from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) program on Friday. Mammoth re

Berkeley’s Innovative Genomics Institute is rolling out a spit test for COVID-19 testing

Scientists from the University of California, Berkeley, have begun trials of a new spit test for COVID-19 infections developed by the university’s Innovative Genomics Institute. Since the diseas

Pioneering CRISPR researcher Jennifer Doudna is coming to Disrupt

Jennifer Doudna, a woman whose work has triggered the explosion in innovation in the field of synthetic biology and has given researchers around the world a way to program and reprogram the living wor

Bit Bio’s ‘enter button for the keyboard to the software of life’ nabs the company $41.5 million

Bit Bio, the new startup that pitches itself as the “enter button for the keyboard to the software of life,” only needed three weeks to raise its latest $41.5 million round of funding. Ori

Mammoth Biosciences partners with GSK to develop handheld CRISPR-based COVID-19 test

California-based Mammoth Biosciences has signed a powerful partner for its development of a CRISPR-based test for COVID-19, which would aim to deliver accurate, fast results using a handheld, disposab
Load More